HQL
abrdn Life Sciences Investors$17.70 −0.03 (−0.17%)
Oct 26 4:00 PM ET · prev $17.73
Market cap
$460.9M
Small cap
1 year
+2.0%
from $17.35 · Oct 27
30 days
−6.3%
from $18.90
52-week range
$15.87–22.67
−22% from high · low Mar 6
Avg volume 20D
123.9K
shares / day
Short interest
🔒 Subscribers only
Insider net
+$10.5K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- B Jul 16 1 insider buy $10.5K at $19.92
- X Jul 31 Short interest falls 70.6% to 18.4K
- X Aug 14 Short interest jumps 217.9% to 58.6K
- X Aug 31 Short interest jumps 70.9% to 100.2K
- X Sep 15 Short interest falls 32.7% to 67.4K
- X Sep 30 Short interest jumps 67.3% to 112.8K
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $10.5K at an average $19.92. No open-market sales. Price is 11% below their cost.
- InstitutionsBULLISH
Q2 2026: 9 added (0 new), 2 trimmed or exited.
- TrendDOWNTREND
9% below its 50-day average.
Who's buying
13F· Q2 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| Allspring Global Investments Holdings, LLC | ADD | $9.1M |
| Steward Partners Investment Advisory, LLC | ADD | $1.4M |
| GUGGENHEIM CAPITAL LLC | ADD | $1.3M |
| STIFEL FINANCIAL CORP | ADD | $1.2M |
| Rockefeller Capital Management L.P. | DOUBLED | $944.8K |
| ENVESTNET ASSET MANAGEMENT INC | DOUBLED | $600.5K |
| Private Advisor Group, LLC | TRIM | $468.3K |
| WOLVERINE ASSET MANAGEMENT LLC | NEAR_EXIT | $151.8K |
Quarterly 13F filings are due 45 days after each quarter ends.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Insider ledger
Form 4$10.5K
bought · 1 insider
$0
sold · 0 insiders
−11.1%
vs their $19.92 cost
| Date | Insider | Type | Value |
|---|---|---|---|
| Jul 16, 2026 | Mahai Chris LaVictoire Director | BUY | $10.5K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 14, 2026 SEC
First Trust Portfolios L.P. and its affiliates filed an amended Schedule 13G for abrdn Life Sciences Investors (HQL)…
SC 13G/A — Impact 3/10
Jul 16, 2026 Insider
Mahai Chris LaVictoire bought 527 shares
Director @ $19.92 ($10.5K)
Jun 30, 2026 Inst.
Allspring Global Investments Holdings, — ADD
455,124 shares ($9.1M)
Jun 30, 2026 Inst.
Steward Partners Investment Advisory, — ADD
68,721 shares ($1.4M)
Jun 2, 2026 Earnings calendar
HQL Q2 2026 Earnings Scheduled — 2026-06-02
SecBot reports
1 filing · 0 bullish · 0 bearish · 1 neutralAll HQL filing & press-release reports (1)
- SC 13G/A reportOct 14, 2026